Atlas Venture Associates Ix, LLC Spero Therapeutics, Inc. Transaction History
Atlas Venture Associates Ix, LLC
- $11.3 Million
- Q3 2023
A detailed history of Atlas Venture Associates Ix, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Associates Ix, LLC holds 1,353,303 shares of SPRO stock, worth $1.8 Million. This represents 14.54% of its overall portfolio holdings.
Number of Shares
1,353,303
Previous 1,353,303
-0.0%
Holding current value
$1.8 Million
Previous $1.96 Million
16.56%
% of portfolio
14.54%
Previous 10.74%
Shares
2 transactions
Others Institutions Holding SPRO
# of Institutions
51Shares Held
15.5MCall Options Held
500Put Options Held
1K-
Anson Funds Management LP Dallas, TX3.75MShares$4.99 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.77MShares$2.35 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$1.43 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny976KShares$1.3 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX919KShares$1.22 Million0.23% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $46.6M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...